Loimer N, Schmid R, Rauch B
Allgemeines Krankenhaus der Stadt Wien, Psychiatrische Universitätsklinik, Osterreich.
Arzneimittelforschung. 1992 Nov;42(11):1346-9.
Individual Dosing in Methadone Maintenance Therapy/Plasma level determination by means of high performance liquid chromatography versus immunoassay. Measuring plasma methadone levels during maintenance therapy is a matter of discussion. Yet, there has been surprisingly little interest in integrating therapeutic drug monitoring into methadone maintenance programmes. The reasons for this are practical. To achieve optimal results during methadone maintenance therapy, a plasma level higher than 200 ng/ml is desired at all times during treatment. In the present study, a total number of 124 plasma samples were estimated twice: by means of HPLC and by means of fluorescence polarization immunoassay (Abbott TDx). The coefficient of correlation was 0.96416. We conclude that therapeutic drug monitoring should become routine in methadone treatment to achieve optimum results, especially in patients who complain of withdrawal symptoms and continue high-risk behaviour. The used immunoassay was found to be safe and inexpensive.
美沙酮维持治疗中的个体化给药/高效液相色谱法与免疫分析法测定血浆水平。在维持治疗期间测定血浆美沙酮水平是一个有争议的问题。然而,将治疗药物监测纳入美沙酮维持治疗项目的兴趣出奇地少。原因是实际操作方面的。为了在美沙酮维持治疗期间取得最佳效果,治疗期间任何时候都希望血浆水平高于200 ng/ml。在本研究中,总共124份血浆样本通过高效液相色谱法(HPLC)和荧光偏振免疫分析法(雅培TDx)进行了两次测定。相关系数为0.96416。我们得出结论,为了取得最佳效果,治疗药物监测应成为美沙酮治疗的常规操作,尤其是对于那些抱怨有戒断症状并持续有高危行为的患者。所使用的免疫分析法被发现既安全又便宜。